graph Evidence gap map comparisons
antibody–drug conjugate
trastuzumab emtansine
Comparator:  vs trastuzumab;   vs trastuzumab plus endocrine therapy;   vs lapatinib plus capecitabine; 
Risk of bias:  low;   some concerns;   high;  NA;